Dense deposit disease is a glomerulopathy of the alternative complement activation (C3 glomerulopathy) with complement deposits located mesangial, subendothelial, subepithelial, and intramembranous.
|
|
|
|||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|||
| 1. |
Brai M et al. (1988) Combined homozygous factor H and heterozygous C2 deficiency in an Italian family.
|
| 2. |
Barbour TD et al. (2013) Dense deposit disease and C3 glomerulopathy.
|
| 3. |
Chen Q et al. (2014) Complement factor H-related hybrid protein deregulates complement in dense deposit disease.
|
| 4. |
Redahan L et al. (2014) Familial MPGN - a case series: a clinical description of familial membranoproliferative glomerulonephritis amongst three Irish families.
|
| 5. |
Xiao X et al. (2014) C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis.
|
| 6. |
Appel GB et al. (2005) Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.
|
| 7. |
None (2002) Complement in glomerulonephritis.
|
| 8. |
Fijen CA et al. (1996) Heterozygous and homozygous factor H deficiency states in a Dutch family.
|
| 9. |
Wyatt RJ et al. (1982) Partial H (beta 1H) deficiency and glomerulonephritis in two families.
|
| 10. |
Nielsen HE et al. (1989) Hereditary, complete deficiency of complement factor H associated with recurrent meningococcal disease.
|
| 11. |
Servais A et al. (2007) Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
|
| 12. |
Licht C et al. (2006) Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).
|
| 15. |
Hegasy GA et al. (2002) The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion.
|
| 16. |
Pickering MC et al. (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.
|
| 17. |
None (2000) Factor H and the pathogenesis of renal diseases.
|
| 18. |
Sánchez-Corral P et al. (2000) Molecular basis for factor H and FHL-1 deficiency in an Italian family.
|
| 19. |
Ault BH et al. (1997) Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism.
|
| 20. |
Høgåsen K et al. (1995) Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.
|
| 21. |
Vogt BA et al. (1995) Inherited factor H deficiency and collagen type III glomerulopathy.
|
| 22. |
Levy M et al. (1986) H deficiency in two brothers with atypical dense intramembranous deposit disease.
|
| 23. |
Orphanet article Orphanet ID 329931
|
| 24. |
OMIM.ORG article Omim 609814
|
| 25. |
Wikipedia article Wikipedia EN (Glomerulonephritis)
|